WeChat Mini Program
Old Version Features

Abstract P1-03-01: Eribulin Versus S-1 As First- or Second- Line Chemotherapy to Assess Health-related Quality of Life and Overall Survival in HER2-negative Metastatic Breast Cancer (RESQ Study): a Non-Inferiority, Randomized Controlled Trial

Yuichiro Kikawa,Kosuke Kashiwabara,Naruto Taira,Tsuguo Iwatani,Kojiro Shimozuma,Shoichiro Ohtani,Tetsuhiro Yoshinami,Junichiro Watanabe,Masahiro Kashiwaba,Ken-ichi Watanabe,Masahiro Kitada,Koichi Sakaguchi,Yuko Tanabe,Tomohiko Aihara,Hirofumi Mukai,Masato Takahashi

Cancer Research（2023）

Cited 0|Views33
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined